Suppr超能文献

鉴定一种可能的克里米亚-刚果出血热病毒进入因子。

Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor.

机构信息

Protein Interactions Group, CCR Nanobiology Program, NCI-Frederick, NIH, Frederick, MD 21702, USA.

出版信息

Biochem Biophys Res Commun. 2011 Jul 29;411(2):253-8. doi: 10.1016/j.bbrc.2011.06.109. Epub 2011 Jun 23.

Abstract

Entry of enveloped viruses into cells is initiated by binding of their envelope glycoproteins (Envs) to cell surface-associated receptors. The Crimean-Congo hemorrhagic fever virus (CCHFV) has two Envs, Gn and Gc, with poorly understood role in binding to susceptible cells. We expressed codon optimized Gn and Gc, and identified independently folded soluble Env fragments, one of which (Gc residues 180-300) bound CCHFV susceptible cells supposedly by interacting with a putative receptor. This receptor binding domain (RBD) was used to identify its interacting partner by coimmunoprecipitation and mass spectrometry. Thus we identified the human cell surface nucleolin as a putative CCHFV entry factor. Nucleolin was expressed on all susceptible cells tested but not on the surface of cells resistant to CCHFV infection. Further studies are needed to explore the nucleolin function as a plausible CCHFV receptor and the molecular mechanisms of the Gc-nucleolin interactions. The identification of the CCHFV RBD and its binding partner could provide novel targets for therapy and tools for prevention as well as more complete understanding of the mechanisms of CCHFV entry and pathogenesis.

摘要

包膜病毒进入细胞是由其包膜糖蛋白(Envs)与细胞表面相关受体的结合启动的。克里米亚-刚果出血热病毒(CCHFV)有两种 Envs,即 Gn 和 Gc,其与易感细胞结合的作用尚不清楚。我们表达了密码子优化的 Gn 和 Gc,并鉴定了独立折叠的可溶性 Env 片段,其中一个(Gc 残基 180-300)通过与假定的受体相互作用结合 CCHFV 易感细胞。该受体结合域(RBD)用于通过共免疫沉淀和质谱鉴定其相互作用伙伴。因此,我们将人类细胞表面核仁素鉴定为潜在的 CCHFV 进入因子。核仁素在所有测试的易感细胞上表达,但不在对 CCHFV 感染有抗性的细胞表面表达。需要进一步研究以探索核仁素作为 CCHFV 受体的功能以及 Gc-核仁素相互作用的分子机制。CCHFV RBD 及其结合伴侣的鉴定可为治疗和预防提供新的靶点,并更全面地了解 CCHFV 进入和发病机制。

相似文献

1
Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor.
Biochem Biophys Res Commun. 2011 Jul 29;411(2):253-8. doi: 10.1016/j.bbrc.2011.06.109. Epub 2011 Jun 23.
2
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus.
Cell Res. 2024 Feb;34(2):140-150. doi: 10.1038/s41422-023-00917-w. Epub 2024 Jan 5.
3
5
Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
Comp Immunol Microbiol Infect Dis. 2019 Dec;67:101371. doi: 10.1016/j.cimid.2019.101371. Epub 2019 Oct 10.
6
Nucleoside-Modified mRNA Vaccines Protect IFNAR Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.
J Virol. 2022 Feb 9;96(3):e0156821. doi: 10.1128/JVI.01568-21. Epub 2021 Nov 24.
7
Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway.
Virology. 2013 Sep;444(1-2):45-54. doi: 10.1016/j.virol.2013.05.030. Epub 2013 Jun 19.
9
A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.
J Virol. 2015 Jun;89(11):5957-67. doi: 10.1128/JVI.03691-14. Epub 2015 Mar 25.

引用本文的文献

2
Lipoprotein receptors: A little grease for enveloped viruses to open the lock?
J Biol Chem. 2024 Nov;300(11):107849. doi: 10.1016/j.jbc.2024.107849. Epub 2024 Sep 30.
3
Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management.
Health Sci Rep. 2024 Sep 2;7(9):e70053. doi: 10.1002/hsr2.70053. eCollection 2024 Sep.
5
Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling.
Biofabrication. 2024 Jun 5;16(3):032008. doi: 10.1088/1758-5090/ad4c0b.
6
Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.
Front Cell Infect Microbiol. 2024 Apr 30;14:1341332. doi: 10.3389/fcimb.2024.1341332. eCollection 2024.
7
Crimean-Congo haemorrhagic fever virus uses LDLR to bind and enter host cells.
Nat Microbiol. 2024 Jun;9(6):1499-1512. doi: 10.1038/s41564-024-01672-3. Epub 2024 Mar 28.
9
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression.
iScience. 2023 Dec 18;27(1):108763. doi: 10.1016/j.isci.2023.108763. eCollection 2024 Jan 19.
10
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus.
Cell Res. 2024 Feb;34(2):140-150. doi: 10.1038/s41422-023-00917-w. Epub 2024 Jan 5.

本文引用的文献

1
Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
Antiviral Res. 2011 May;90(2):85-92. doi: 10.1016/j.antiviral.2011.02.010. Epub 2011 Mar 6.
2
Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.
Angiogenesis. 2009;12(1):91-100. doi: 10.1007/s10456-009-9137-5. Epub 2009 Feb 19.
3
Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle.
Virology. 2009 Mar 15;385(2):313-22. doi: 10.1016/j.virol.2008.11.020. Epub 2009 Jan 15.
7
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin.
Blood. 2007 Oct 15;110(8):2899-906. doi: 10.1182/blood-2007-01-064428. Epub 2007 Jul 5.
8
Nucleolin: a multiFACeTed protein.
Trends Cell Biol. 2007 Feb;17(2):80-6. doi: 10.1016/j.tcb.2006.11.010. Epub 2006 Dec 8.
9
Crimean-Congo haemorrhagic fever.
Lancet Infect Dis. 2006 Apr;6(4):203-14. doi: 10.1016/S1473-3099(06)70435-2.
10
A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells.
J Biol Chem. 2005 Nov 25;280(47):39284-93. doi: 10.1074/jbc.M505275200. Epub 2005 Aug 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验